Tianjin builds a collaborative innovation platform for drug R&D transformation and strives to create a “handshake channel” for new drug incubation and transformation

[ad_1]

On April 26, the “Tianjin Drug R&D Transformation Collaborative Innovation Platform” led by Tianjin Municipal Market Supervision and Administration Commission and Tianjin Drug Administration was officially launched. This is a concrete measure to fully implement the spirit of the 20th National Congress of the Communist Party of China and promote the study and implementation of Xi Jinping’s new era of socialism with Chinese characteristics. The “Five Major Projects of Market Supervision” is a powerful starting point for practical and effective results, and it is also an important link to promote the coordinated development of the Beijing-Tianjin-Hebei region and actively strive for innovation resources in Beijing. Zhang Wei, President of China Drug Administration Research Association, Li Shao, Director of Beijing Institute of Traditional Chinese Medicine, Tsinghua University, Municipal Market Supervision Commission, Municipal Food and Drug Administration, Municipal Science and Technology Bureau, Municipal Industry and Information Technology Bureau, Municipal Health Commission, Municipal Relevant comrades from the Medical Insurance Bureau, more than 200 representatives from 31 drug clinical trial institutions and 127 drug manufacturers in our city, scientific research institutes such as Tianjin Medical University and Tianjin University of Traditional Chinese Medicine, and drug research and development supporting companies attended the launching ceremony of the platform.

“Tianjin Drug R&D Transformation Collaborative Innovation Platform” integrates all drug clinical trial institutions, drug manufacturers, and drug R&D units in the city, as well as well-known universities and research institutes such as Tsinghua University, Tianjin Medical University, Tianjin University of Traditional Chinese Medicine, etc. From the “handshake channel” of the whole process of production, relying on the platform to realize the innovation of drug categories, drug varieties, accelerate clinical research, and promote vaccine research and development. Encourage the research and development of original drugs and the single-point breakthrough of innovative drugs, establish an effective rapid development channel from drug research and development to production, accelerate the incubation and transformation of new drugs, help drugs with better clinical value to be launched, and promote the high-quality development of the biomedical industry in our city .

At the kick-off meeting, Tianjin Municipal Market Supervision and Administration Commission, Tianjin Municipal Drug Administration and Tsinghua University signed a cooperation project “Research on Application Evaluation of Modern Chinese Medicine Network Target Technology”, Tianjin Municipal Drug Administration and Tianjin University of Traditional Chinese Medicine signed ” To explore the establishment of the cooperation project of “Technical Guidelines for Drug Evaluation”, Tianjin Modern Traditional Chinese Medicine Innovation Center, Tianjin Cancer Hospital, Tianjin Eye Hospital, and Tianjin Medical University Zhu Xianyi Memorial Hospital jointly signed the cooperation project “Secondary Development of Preparations in Medical Institutions” to jointly develop drugs Cooperate on projects such as regulatory scientific research, overall analysis of the mechanism of action of traditional Chinese medicine and precise quality control positioning, medical institution preparation standards and process improvement, and assistance in the secondary development of “sleeping varieties” to further realize complementary advantages and jointly promote Tianjin’s biopharmaceutical industry to reach new heights Step up and create a new situation.

[ad_2]

Source link